Skip to main content
. 2017 Aug 30;7:9982. doi: 10.1038/s41598-017-10155-x

Figure 4.

Figure 4

cd2068 C. difficile mutant exhibited increased drug susceptibility. (a) Verification of the cd2068 mutant in C. difficile. (Top panel) schematic cartoons illustrated the cd2068 gene before and after retro-transposition of the intron, arrows indicate primer used for verification. (Bottom panel) Agarose gel electrophoresis of PCR products amplified using corresponding set of primers. M represents DNA ladder; Lane 1 represents pMTL007C-E2:cd2068 plasmid; Lanes 2, 4 and 6 represent C. difficile Δerm (control); Lanes 3, 5 and 7 represent cd2068 mutant. Lanes 1–3, 4–5, and 6–7 were amplified using RAM-F/RAM-R, EBS universal/CD2068-R, and CD2068-F/CD2068-R, respectively. (b) Disruption of cd2068 in C. difficile enhanced antibiotic susceptibility, which was genetically complemented with the cd2068 gene. Agar well diffusion assays were performed on the cd2068 mutant versus control C. difficile as well as the cd2068 mutants carrying pMTL84151 and pMTL-cd2068 in the presence of various concentrations of ciprofloxacin.